Modelling the impact of cuts in US PEPFAR funding for opioid agonist therapy and needle and syringe programmes on drug-related deaths and HIV and hepatitis C transmission among people who inject drugs.
- DOI
- 10.1016/j.drugpo.2026.105290
- Published
- 2026 Jun
- Container
- The International journal on drug policy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.drugpo.2026.105290,
title = {Modelling the impact of cuts in US PEPFAR funding for opioid agonist therapy and needle and syringe programmes on drug-related deaths and HIV and hepatitis C transmission among people who inject drugs.},
author = {Mutai KK and Estadilla CDS and Artenie A and Ogunkola I and Montgomery R and Madden A and Basenko A and Gurung G and Cook C and Stone J and Vickerman P},
year = {2026},
journal = {The International journal on drug policy},
doi = {10.1016/j.drugpo.2026.105290},
url = {https://doi.org/10.1016/j.drugpo.2026.105290}
}RIS
TY - JOUR TI - Modelling the impact of cuts in US PEPFAR funding for opioid agonist therapy and needle and syringe programmes on drug-related deaths and HIV and hepatitis C transmission among people who inject drugs. AU - Mutai KK AU - Estadilla CDS AU - Artenie A AU - Ogunkola I AU - Montgomery R AU - Madden A AU - Basenko A AU - Gurung G AU - Cook C AU - Stone J AU - Vickerman P PY - 2026 JO - The International journal on drug policy DO - 10.1016/j.drugpo.2026.105290 UR - https://doi.org/10.1016/j.drugpo.2026.105290 ER -
APA
KK, M., CDS, E., A, A., I, O., R, M., A, M., A, B., G, G., C, C., J, S., & P, V. (2026). Modelling the impact of cuts in US PEPFAR funding for opioid agonist therapy and needle and syringe programmes on drug-related deaths and HIV and hepatitis C transmission among people who inject drugs.. The International journal on drug policy. https://doi.org/10.1016/j.drugpo.2026.105290
Source records
- pubmed · retrieved 2026-09-26T21:27:19.850Z